農場動物疼痛緩解和預防市場－全球產業規模、佔有率、趨勢、機會和預測：按動物類型、產品類型、給藥途徑、最終用戶、地區和競爭格局分類，2021-2031年

全球牲畜疼痛緩解和預防市場預計將從 2025 年的 571.3 億美元大幅成長至 2031 年的 985.3 億美元，複合年成長率為 9.51%。

該市場涵蓋多種藥品，例如非類固醇消炎劑(NSAIDs)、麻醉劑和鎮痛劑，以及旨在減輕牲畜在日常操作和疾病期間疼痛的醫療設備。推動該市場成長要素包括：日益嚴格的監管要求，要求人道對待動物；動物福利改善與生產效率提高之間已確立的聯繫；以及消費者對符合倫理規範生產的肉類和乳製品的日益成長的偏好。所有這些因素都促使生產者將疼痛管理視為一項核心實踐，而非曇花一現的趨勢。

然而，生產者面臨的沉重經濟負擔限制了市場成長。對於利潤微薄的農業部門而言，購買和使用這些止痛藥的成本可能過高。根據澳洲動物藥品協會預測，到2024年，澳洲獸藥銷售額將達到6.37億美元，凸顯了畜牧業健康領域現有的巨額投資，而這些投資本身就需要大量的資本支出。如果沒有強力的經濟獎勵，這將有效地延緩更多止痛療法的推廣應用。

市場促進因素

嚴格的畜牧福利監管要求是全球農場動物疼痛緩解和預防市場的主要驅動力，促使世界各國政府實施相關規程，將侵入性動物飼養作業中使用鎮痛藥和麻醉劑作為強制性要求，而非可選項。這項監管轉變將規範整個產業的獸醫干預措施，減少因經濟環境變化和營運差異造成的動物照護差異。美國農業部在其2024財政年度預算摘要（截至2024年3月）中撥款3,900萬美元用於動物福利活動，旨在確保對保護標準的全面執行和監督，這便是對監管工作的一種財政支持。

同時，消費者對符合高福利標準的、以符合倫理道德的方式生產的動物產品的需求日益成長，迫使生產者實施先進的疼痛管理策略。隨著大眾對食品價值鏈的了解不斷加深，消費者正利用其購買力支持那些優先考慮人道待遇的品牌，因此，農民也被鼓勵投資於疼痛管理解決方案，以確保市場准入並提升品牌價值。歐洲消費者組織2024年2月發布的報告顯示，十分之七的消費者願意為符合更高福利標準的食品支付額外費用。這一趨勢正在增強提供此類治療方案的主要市場參與者的財務基礎，例如，碩騰公司（Zoetis Inc.）在2025年公佈的2024年全年銷售額為93億美元。這反映了在不斷變化的福利期望的推動下，動物保健行業持續成長。

市場挑戰

全球畜牧業疼痛緩解和預防市場的成長受到畜牧養殖戶面臨的巨大經濟壓力的顯著限制。在利潤率普遍較低的農業領域，購買和使用鎮痛藥、麻醉劑和非類固醇消炎劑）的成本會直接增加營運成本，即使這些藥物並非總是能立即產生切實可見的投資回報。由於止痛藥通常被視為可有可無的支出，不像飼料添加劑那樣直接促進增重，因此在商品價格波動和投入成本飆升時期，生產者為了維持財務永續性，往往會降低福利性藥物的優先級。這導致這些重要治療方法的廣泛應用受到阻礙。

雪上加霜的是，維持基本的動物健康標準本身就需要大量資金。生產者的預算有限，資金競爭又異常激烈，這使得實施專有的疼痛管理方案成為一項沉重的額外經濟負擔。根據動物健康研究所估計，到2024年，美國動物用藥品市場規模約為99億美元，顯示該領域目前的支出水準極高。這說明生產者已經在獸醫護理方面投入巨資，而在如此高成本的環境下，止痛產品的額外成本往往會成為阻礙市場擴張的障礙，即便存在有效的治療方法。

市場趨勢

精準動物養殖（PLF）技術應用於疼痛檢測，透過自動識別牲畜群中的痛苦徵兆，正在改變市場格局。 PLF利用感測器和電腦視覺技術監測跛行和叫聲等指標，有效克服了動物在人工檢查中隱藏不適的自然傾向。這項技術進步實現了數據驅動的早期干預，從而預防長期痛苦和由此造成的生產損失。大型生產商正在迅速採用這些技術。根據美國農業部2024年12月發布的報告《美國農場和牧場概覽：2024版》，12%的大型農場已開始使用穿戴式動物健康監測技術，為建構自動化疼痛評估體系奠定了基礎。

同時，長效型止痛藥的研發正在解決大規模畜牧場頻繁給藥所帶來的後勤挑戰。生產商正在開發具有緩釋特性和經皮給藥系統的藥物，從而降低重複給藥帶來的人事費用和動物壓力。這項創新滿足了生產者對持續數天而非數小時的治療方法的需求，確保符合動物福利標準，同時又不干擾日常農場運作。這些先進療法的商業性可行性顯而易見。禮來動物保健公司（Elanco Animal Health）在2025年2月發布的2024年第四季及全年財報中指出，其創新產品組合的收入達到4.61億美元，凸顯了市場對尖端動物用藥品解決方案的強勁需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球農場動物疼痛緩解與預防市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 動物種類（牛、豬、家禽、馬等）
  • 產品類型（非類固醇抗發炎藥、鴉片類藥物、麻醉劑、α-2促效劑、皮質類固醇、局部麻醉劑、其他）
  • 給藥途徑（口服、注射、外用、其他）
  • 依最終使用者（畜牧養殖戶、獸醫院/診所、研究機構等）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美畜牧業疼痛緩解與預防市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章 歐洲農場動物疼痛緩解與預防市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區農場動物疼痛緩解與預防市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲農場動物疼痛緩解和預防市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲畜牧業疼痛緩解與預防市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球農場動物疼痛緩解與預防市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Bayer AG
• Neogen Corporation
• Merck & Co., Inc.
• Ceva Sante Animale SA
• Virbac SA
• Vetoquinol SA
• Norbrook Laboratories Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Farm Animal Pain Relief and Prevention Market is projected to expand significantly, from USD 57.13 Billion in 2025 to USD 98.53 Billion by 2031, demonstrating a 9.51% Compound Annual Growth Rate. This market includes a variety of pharmaceuticals such as NSAIDs, anesthetics, and analgesics, as well as medical devices aimed at alleviating pain in livestock during standard procedures or illness. Key growth accelerators for this market involve stricter regulatory requirements for humane animal treatment, the established link between enhanced animal welfare and greater production efficiency, and increasing consumer preference for ethically produced meat and dairy, all of which drive producers to adopt pain management as a core practice rather than a fleeting trend.

Nonetheless, the market's growth is constrained by considerable economic burdens on producers, where the expenditures for acquiring and administering these pain relief solutions can be excessively high for agricultural sectors operating on narrow profit margins. The existing substantial investment in livestock health, exemplified by 2024 sales of veterinary products for production animals reaching 637 million dollars in Australia according to Animal Medicines Australia, underscores the significant capital outlay already required, which inherently slows the integration of further pain relief therapies without compelling financial incentives.

Market Driver

Stringent regulatory mandates concerning livestock welfare are a primary driver for the Global Farm Animal Pain Relief and Prevention Market, compelling governments globally to enforce protocols that make the use of analgesics and anesthetics during invasive husbandry procedures a compliance requirement rather than an optional practice. This regulatory shift standardizes veterinary interventions across the industry, mitigating variations in animal care due to economic shifts or operational differences. The financial backing for this oversight is demonstrated by the United States Department of Agriculture's allocation of 39 million dollars for Animal Welfare activities in its 'FY 2024 Budget Summary' as of March 2024, aimed at ensuring robust enforcement and monitoring of protection standards.

Concurrently, increasing consumer demand for ethically produced and high-welfare animal products is urging producers to implement advanced pain mitigation strategies. As public understanding of food supply chains grows, consumers are using their purchasing power to support brands that prioritize humane treatment, thus incentivizing farmers to invest in pain relief solutions to secure market access and enhance brand value. A February 2024 report by the European Consumer Organisation indicated that 7 out of 10 consumers are willing to pay more for food from higher welfare standards. This trend bolsters the financial health of key market players providing these therapeutics, with Zoetis Inc. reporting 9.3 billion dollars in full-year 2024 revenue in 2025, reflecting the ongoing economic scale of the animal health sector fueled by these evolving welfare expectations.

Market Challenge

The Global Farm Animal Pain Relief and Prevention Market's growth is significantly hindered by considerable economic pressures on livestock producers. Within agricultural sectors characterized by narrow profit margins, the expenses for acquiring and administering analgesics, anesthetics, and NSAIDs directly escalate operational costs without consistently delivering an immediate, tangible return on investment. Since pain mitigation is often perceived as a discretionary expense, unlike feed additives that directly contribute to weight gain, producers frequently deprioritize welfare-specific medications during periods of fluctuating commodity prices or escalating input costs to maintain financial viability, consequently impeding the widespread adoption of these crucial therapies.

This issue is further compounded by the substantial capital already required to uphold fundamental animal health standards. Producers operate with constrained budgets, and the competition for these funds is intense, making the incorporation of distinct pain management protocols a significant additional financial burden. The United States animal health pharmaceutical market, valued at approximately 9.9 billion dollars in 2024 according to the Animal Health Institute, illustrates the immense existing expenditure in this sector. This demonstrates that producers are already heavily invested in veterinary care, and in such a high-cost environment, the extra expense of pain relief products frequently becomes prohibitive, thus stifling market expansion despite the availability of effective treatments.

Market Trends

The integration of Precision Livestock Farming (PLF) for pain detection is transforming the market by automating the identification of distress signals within animal herds. PLF employs sensors and computer vision to monitor indicators such as lameness and vocalization, effectively overcoming the natural inclination of prey species to conceal discomfort during manual inspections. This technological advancement facilitates earlier, data-driven interventions, thereby preventing prolonged suffering and related production losses. Adoption of these technologies is notably increasing among major producers; the United States Department of Agriculture's December 2024 'America's Farms and Ranches at a Glance: 2024 Edition' report indicated that wearable livestock technologies for health monitoring were adopted by 12 percent of large-scale farms, thereby laying the groundwork for automated pain assessment infrastructure.

Simultaneously, the creation of long-acting analgesic formulations is addressing the logistical difficulties associated with frequent drug administration in extensive farming operations. Manufacturers are developing pharmaceuticals with extended-release profiles or transdermal delivery systems, which reduce both the labor costs and the stress on animals linked to repeated dosing. This innovation caters to producers' requirements for therapeutic regimens that sustain efficacy for days instead of hours, ensuring welfare compliance without interrupting daily farm activities. The commercial viability of these advanced therapeutics is clear, with Elanco Animal Health reporting 461 million dollars in revenue from its innovation portfolio in its February 2025 'Fourth Quarter and Full Year 2024 Results,' highlighting a robust market demand for cutting-edge animal health solutions.

Key Market Players

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Bayer AG
• Neogen Corporation
• Merck & Co., Inc.
• Ceva Sante Animale S.A.
• Virbac S.A.
• Vetoquinol S.A.
• Norbrook Laboratories Ltd.

Report Scope

In this report, the Global Farm Animal Pain Relief and Prevention Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Farm Animal Pain Relief and Prevention Market, By Animal Type

• Cattle
• Swine
• Poultry
• Equine
• Others

Farm Animal Pain Relief and Prevention Market, By Product Type

• NSAIDs
• Opioids
• Anesthetics
• Alpha-2 Agonists
• Corticosteroids
• Local Anesthetics
• Others

Farm Animal Pain Relief and Prevention Market, By Route of Administration

• Oral
• Injectable
• Topical
• Others

Farm Animal Pain Relief and Prevention Market, By End User

• Livestock Farmers
• Veterinary Clinics & Hospitals
• Research Institutes
• Others

Farm Animal Pain Relief and Prevention Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Farm Animal Pain Relief and Prevention Market.

Available Customizations:

Global Farm Animal Pain Relief and Prevention Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Farm Animal Pain Relief and Prevention Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Cattle, Swine, Poultry, Equine, Others)
  • 5.2.2. By Product Type (NSAIDs, Opioids, Anesthetics, Alpha-2 Agonists, Corticosteroids, Local Anesthetics, Others)
  • 5.2.3. By Route of Administration (Oral, Injectable, Topical, Others)
  • 5.2.4. By End User (Livestock Farmers, Veterinary Clinics & Hospitals, Research Institutes, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Farm Animal Pain Relief and Prevention Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product Type
  • 6.2.3. By Route of Administration
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By End User

7. Europe Farm Animal Pain Relief and Prevention Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product Type
  • 7.2.3. By Route of Administration
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By End User
  • 7.3.2. France Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By End User

8. Asia Pacific Farm Animal Pain Relief and Prevention Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product Type
  • 8.2.3. By Route of Administration
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By End User
  • 8.3.2. India Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By End User

9. Middle East & Africa Farm Animal Pain Relief and Prevention Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product Type
  • 9.2.3. By Route of Administration
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By End User

10. South America Farm Animal Pain Relief and Prevention Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product Type
  • 10.2.3. By Route of Administration
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Farm Animal Pain Relief and Prevention Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zoetis Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boehringer Ingelheim International GmbH
• 15.3. Elanco Animal Health Incorporated
• 15.4. Bayer AG
• 15.5. Neogen Corporation
• 15.6. Merck & Co., Inc.
• 15.7. Ceva Sante Animale S.A.
• 15.8. Virbac S.A.
• 15.9. Vetoquinol S.A.
• 15.10. Norbrook Laboratories Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer